Safety and efficacy of Profermin&reg; to induce remission in ulcerative colitis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 15

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

434

HTML

4149

Figures (1-4)

193

Tables (1-4)

116

Sum=4892

Apr 21, 2012 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Apr 21, 2012; 18(15): 1773-1780
Published online Apr 21, 2012. doi: 10.3748/wjg.v18.i15.1773

Table 4 Concomitant medications

	n (%)
Mesalamine oral
Alone	21 (54)
Combined with immunosuppressants	8 (21)
Mesalamine enema or suppository	6 (15)
Azathioprine or 6-mercaptopurine	3 (8)
Corticosteroids oral	0 (0)
Corticosteroids enema	1 (3)
Antibiotics	0 (0)
TNF-α inhibitors	3 (8)
None	3 (8)

TNF-α: Tumor necrosis factor alpha.

Citation: Krag A, Israelsen H, Ryberg BV, Andersen KK, Bendtsen F. Safety and efficacy of Profermin^® to induce remission in ulcerative colitis. World J Gastroenterol 2012; 18(15): 1773-1780
URL: https://www.wjgnet.com/1007-9327/full/v18/i15/1773.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i15.1773